biotech / news / / MarketScreener
Eli Lilly and Company announced an additional $4.5 billion investment across two of its three Lebanon sites?bringing the company's total Indiana capital expansion commitments since 2020 to more than $21 billion.
Eli Lilly is investing an additional $4.5 billion in two Lebanon, Indiana, manufacturing sites.
KEY POINTS
- Lilly Lebanon Advanced Therapies is their first genetic medicine manufacturing facility and opens today.
- The facility developed entirely new manufacturing processes for genetic modalities with no commercial precedent.
- Lilly's Lebanon API site will also produce Foundayo and potentially retatrutide, expanding beyond tirzepatide.
COMPANIES
Summarized by Newsio from MarketScreener. How we summarize →